Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

FDA Approves First New Drug for AML Since 1990 FDA Approves First New Drug for AML Since 1990
Midostaurin is indicated for the treatment of patients with newly diagnosed acute myeloid leukemia who have the FLT3 genetic mutation.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Breast Surgeon Found Guilty of ' Wounding With Intent ' Breast Surgeon Found Guilty of ' Wounding With Intent '
After years of questions over his surgery on breast cancer patients, a criminal court has found Ian Paterson guilty of ' wounding with intent. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First New Drug for Liver Cancer in a Decade: Regorafenib First New Drug for Liver Cancer in a Decade: Regorafenib
The FDA has approved an expanded indication for regorafenib to include hepatocellular carcinoma, making it the first drug to be approved for this cancer in a decade.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Dramatic Jump in Incidence of NETs Over Past 4 Decades Dramatic Jump in Incidence of NETs Over Past 4 Decades
The incidence of neuroendocrine tumors (NETs) has increased dramatically over the past 4 decades, but the rise may be due to improved diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Renowned Neurosurgeon on Assisted Dying and His ' Suicide Kit ' Renowned Neurosurgeon on Assisted Dying and His ' Suicide Kit '
Releasing a second memoir of his experiences resecting brain tumors, Henry Marsh, FRCS, also talks about assisted dying and his own suicide kit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Troubles of the Billionaire ' Moonshot ' Doctor Troubles of the Billionaire ' Moonshot ' Doctor
Only months after being in the spotlight as a potential player in the Trump administration, a wealthy doctor is beset by a rash of controversiesMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Issues Guideline on Castrate-Resistant Prostate Cancer ASCO Issues Guideline on Castrate-Resistant Prostate Cancer
The new document, a provisional clinical opinion, offers guidelines for treating chemotherapy-naive men who develop castrate-resistant prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Takes Action Against ' Bogus Cancer Cures ' FDA Takes Action Against ' Bogus Cancer Cures '
The FDA has sent warning letters to 14 companies that are ' peddling bogus cancer cures ' and are exploiting the cancer patients ' desperation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Many Men Have No Discussion of Pros and Cons Before PSA Test Many Men Have No Discussion of Pros and Cons Before PSA Test
A national survey shows that less than one third of men are discussing the pros and cons of prostate-specific antigen testing with their healthcare provider before undergoing screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe
Two biosimilar rituximab products have been recommended for approval in Europe, as has inotuzumab ozogamicin for acute lymphoblastic leukemia.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Possibility of ' Cure ' for Metastatic Prostate Cancer Possibility of ' Cure ' for Metastatic Prostate Cancer
A small study in 20 men with early-stage extrapelvic and bone metastases shows that aggressive multimodal therapy ' can eliminate detectable disease. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASTRO Releases First Guidelines for Oropharyngeal Cancer ASTRO Releases First Guidelines for Oropharyngeal Cancer
ASTRO releases its first guidelines for the management of oropharyngeal cancer but purposefully avoids distinguishing between HPV-positive and -negative disease despite differences in prognosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Strategies to Curb Drug Costs Affect Patient Care, Says ASCO Strategies to Curb Drug Costs Affect Patient Care, Says ASCO
Current utilization management policies used by health insurance companies to control drug costs may negatively affect patients with cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Brazil ' s Phospho Cancer Cure Frenzy: A Cautionary Tale Brazil ' s Phospho Cancer Cure Frenzy: A Cautionary Tale
Brazil ' s tale of a ' miracle cancer pill ' showcases how a mix of academic carelessness, political opportunism, and mistrust of science can turn into an explosive situation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Patients Vary Widely on Adjuvant Chemo -- Critical to Ask Patients Vary Widely on Adjuvant Chemo -- Critical to Ask
A new study finds that patients with early breast cancer differ with regard to their preferences for adjuvant chemotherapy; some want it, some do not, regardless of survival benefit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Further Immortalization of Henrietta Lacks The Further Immortalization of Henrietta Lacks
From her tumor cells to her life story as a woman, mother, and guiding light, Henrietta Lacks was extraordinary. She is the subject of a new movie.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Atezolizumab for Urothelial Cancer, Now Also First-Line Atezolizumab for Urothelial Cancer, Now Also First-Line
Already approved for use in metastatic urothelial carcer, the immunotherapy atezolizumab (Tencentriq, Genentech) can now be used as a first-line treatment.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Really, Men With Prostate Cancer Do Yoga Really, Men With Prostate Cancer Do Yoga
In a first-of-a-kind study, patients with prostate cancer who did yoga during radiotherapy reported less fatigue and better sexual and urinary function than those who didn ’ t.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Destroy Them: One Way to Up Price of Generic Cancer Drugs Destroy Them: One Way to Up Price of Generic Cancer Drugs
In the midst of a dispute with health authorities in Spain, an Aspen Pharmacare executive proposed the idea of destroying generic cancer drugs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Drops Prescriber Training for ESAs in Chemo Patients FDA Drops Prescriber Training for ESAs in Chemo Patients
The agency concluded that clinicians have a better handle on prescribing the erythropoiesis-stimulating agents for chemotherapy-related anemia and understanding their risks.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 14, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

New Approaches Needed for Peritoneal Metastases in CRC New Approaches Needed for Peritoneal Metastases in CRC
Dr David Kerr challenges the oncology community to come up with rational, meaningful clinical trials to clarify the biology of metastatic peritoneal disease in colorectal cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Antineoplastic Agents in Breast Cancers With Mutational Signatures Antineoplastic Agents in Breast Cancers With Mutational Signatures
Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Appropriate Use of Bone Scintigraphy to Diagnose Metastases Appropriate Use of Bone Scintigraphy to Diagnose Metastases
Beginning next year, clinicians will need to consult these new appropriate use criteria (AUC) for bone scintigraphy for bone metastases in cancer patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncologists ' Income in 2017 About the Same as Last Year Oncologists ' Income in 2017 About the Same as Last Year
This year ' s Medscape Physician Compensation Report places US oncologists in about the middle of the pack compared to other specialists, with almost all respondents saying they made the right choice when selecting their specialty.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Increase in Childhood Cancer, but Survival Rates High Increase in Childhood Cancer, but Survival Rates High
The incidence of childhood cancers has increased in recent decades.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Local Consolidation Therapy for Oligometastatic NSCLC Local Consolidation Therapy for Oligometastatic NSCLC
Dr Jack West analyzes results of a provocative study testing local consolidation therapy in oligometastatic NSCLC, including how the results might guide clinical practice.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Individualize, ' Says Prostate Cancer Screening From USPSTF ' Individualize, ' Says Prostate Cancer Screening From USPSTF
In an update to prostate screening guidance, the task force says that for men from 55 to 69 years of age, the decision to screen must be an individual one.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Value-Based Oncology Care an Imperfect Proposition Still Value-Based Oncology Care an Imperfect Proposition Still
ASCO said its value framework is still not ready for use, while a cancer center shared how it has implemented the Oncology Care Model, but has no data yet.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rice Bran, Bean Powder Might Reduce Colorectal Cancer Risk Rice Bran, Bean Powder Might Reduce Colorectal Cancer Risk
Diet supplemented with high-fiber rice bran and navy bean powder produces beneficial changes in the gut that might reduce colorectal cancer risk over time.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Gauging Appropriate Care for Older Breast Cancer Patients Gauging Appropriate Care for Older Breast Cancer Patients
Reviewing the latest clinical management tools, Dr Arti Hurria talks about caring for the geriatric oncology patient long-term, without burning out.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Long-Term Aspirin May Cut Risk for Cancer Death Long-Term Aspirin May Cut Risk for Cancer Death
Long-term, regular aspirin use was associated with a reduced relative risk for both death from any cause and from various cancers, in a big observational study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Does Not Support ' Right-to-Try ' Laws ASCO Does Not Support ' Right-to-Try ' Laws
ASCO ' s all in favor of helping cancer patients gain better access to experimental drugs in their time of need, but not through ' right-to-try ' legislation, which they feel could be harmful.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Excited ' : Reaction to Advanced Melanoma Combo ' Excited ' : Reaction to Advanced Melanoma Combo
The combination of pembrolizumab and an experimental agent yielded a response rate of more than 50%. Oncologists responded with some emotion.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Childhood Cancer Survivors: Genetic Risk for Future Cancers? Childhood Cancer Survivors: Genetic Risk for Future Cancers?
The first large-scale whole-genome sequencing study of childhood cancer survivors shows that around 12% have mutations that increase cancer risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Guideline for Sexual/Gender Minority Cancer Patients ASCO Guideline for Sexual/Gender Minority Cancer Patients
Patients from sexual/geneder minority groups, including lesbians and gays, face unique challenges when it comes to cancer care, including discrimination.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nivolumab Quadruples 5-Year Survival in NSCLC Nivolumab Quadruples 5-Year Survival in NSCLC
The longest follow-up to date on patients treated with nivolumab (Opdivo) for advanced non-small cell lung cancer shows a 5-year overall survival rate four times higher than without treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First Survival Results With Immunotherapy, TNBC First Survival Results With Immunotherapy, TNBC
The immunotherapy atezolizumab produces responses in a small percentage of triple-negative breast cancer (TNBC) but with a long duration of response.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biomarkers to Determine Who Gets Checkpoint Inhibitors Biomarkers to Determine Who Gets Checkpoint Inhibitors
Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

It ' s ' Wacky ' but Improves Survival in Glioblastoma It ' s ' Wacky ' but Improves Survival in Glioblastoma
A device that uses electric ' tumor treating fields ' to treat brain cancer is ' outside the box ' but is also FDA-approved, and final phase 3 data are now available.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Precision Medicine Zeros in on HER2 in Colorectal Cancer Precision Medicine Zeros in on HER2 in Colorectal Cancer
But other research suggests HER2 positivity means different things in different cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Novel Agent Eryaspase in Metastatic Pancreatic Cancer Novel Agent Eryaspase in Metastatic Pancreatic Cancer
Phase 2 data showed significant improvement in both progression-free and overall survival in patients treated with novel agent eryaspase.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Full FDA Approval for Osimertinib for PFS Benefit in NSCLC Full FDA Approval for Osimertinib for PFS Benefit in NSCLC
The targeted drug has now shown an improvement in progression-free survival when compared to chemotherapy in certain NSCLC patients.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Early Colorectal Cancer: Missing the Clues? Early Colorectal Cancer: Missing the Clues?
Researchers, clinicians, survivors and their caretakers convene at the EAO-CRC Symposium to review the rapidly increasing incidence of rectal and colon cancer among young adults.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

Routine PSA Screening: Still No Clarity on Usefulness Routine PSA Screening: Still No Clarity on Usefulness
Experts from the National Cancer Institute note that research is needed on how to reduce the harms of PSA screening while keeping any benefit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radiotherapy for Breast Cancer Harmful in Smokers Radiotherapy for Breast Cancer Harmful in Smokers
In patients with breast cancer who are long-term smokers, the risk of radiotherapy may outweigh benefits, so smoking cessation should be urged.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Higher Cancer Deaths in Patients With Learning Difficulties Higher Cancer Deaths in Patients With Learning Difficulties
The cancer-specific mortality rate was four-fold higher in patients with testicular cancer who also had learning difficulties than in those without.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Dramatic Increase in Incidence of Penile Cancer Precursor Dramatic Increase in Incidence of Penile Cancer Precursor
The rates of penile carcinoma in situ, a premalignant precursor of penile cancer, have increased dramatically in recent years in England.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New US Cancer Staging System Debuts in 9 Months New US Cancer Staging System Debuts in 9 Months
The American Joint Committee on Cancer has a new staging system that elevates ' prognostic ' status as the official staging classification of every cancer in the United States.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

BRCA Testing Has Skyrocketed, but Misses High-Risk Women BRCA Testing Has Skyrocketed, but Misses High-Risk Women
Although there has been a huge increase in BRCA mutation testing during the past decade, current guidelines and clinical practice do not include many women who are at high risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

SWISH Four Times a Day to Keep Oral Mucositis Away SWISH Four Times a Day to Keep Oral Mucositis Away
A swish-and-spit steroid mouthwash regimen that dramatically reduces the symptoms of treatment-induced oral mucositis should become a new standrd of care, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news